Enables Bristol Myers Squibb to expand its manufacturing capacity, meeting the growing demand for its range of cell therapies through Cellares’ platform.
This webinar on May 1 will explore several alternative clinical supply models, use cases and identify key considerations when adopting one of these models.
Meeson will bring his expertise to Axplora’s global footprint of 10 sites on 3 continents while continuing to amplify the group’s capabilities and strengths.